SCHEMBL13065729

SCHEMBL13065729

COc1ccc(-c2c(C(=O)O)c3nc4ccccc4oc-3c(O)c2=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.51
ALDH1A1 P00352 6/20 0.51
CYP3A4 P08684 2/20 0.51
HSD17B10 Q99714 2/20 0.51
ABCG2 Q9UNQ0 3/20 0.47
MAOB P27338 1/20 0.46
MAPT P10636 3/20 0.43
MEN1 O00255 1/20 0.43
TP53 P04637 1/20 0.43
HPGD P15428 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 4/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
DHODH Q02127 2/20 0.42
ATM Q13315 1/20 0.42
LMNA P02545 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065730 0.90 ABCG2 (0.50) KDM4EALDH1A1CYP3A4HSD17B10ABCG2
SCHEMBL13065731 0.89 DHODH (0.47) KDM4EALDH1A1CYP3A4HSD17B10ABCG2
SCHEMBL13065733 0.89 KDM4E (0.53) KDM4EALDH1A1CYP3A4HSD17B10MAPT
SCHEMBL13065735 0.88 LMNA (0.48) KDM4EALDH1A1CYP3A4MAPTMEN1
SCHEMBL13065738 0.87 HPGD (0.42) KDM4EALDH1A1CYP3A4HSD17B10MAPT
SCHEMBL13065732 0.86 MAPK14 (0.45) KDM4ECYP3A4MAPTMEN1TP53
SCHEMBL16784744 0.85 PDE10A (0.40) KDM4EALDH1A1CYP3A4HSD17B10MAPT
SCHEMBL16784715 0.84 TP53 (0.42) KDM4EALDH1A1CYP3A4HSD17B10ABCG2
SCHEMBL13065740 0.83 LMNA (0.39) KDM4ECYP3A4MAPTMEN1TP53
SCHEMBL13065737 0.83 DHODH (0.39) KDM4EALDH1A1CYP3A4HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 KDM4E 4062/4885ALDH1A1 4382/4885CYP3A4 4203/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 KDM4E 4062/4885ALDH1A1 4382/4885CYP3A4 4203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.